WallStSmart
KALV

Kalvista Pharmaceuticals Inc

NASDAQ: KALV · HEALTHCARE · BIOTECHNOLOGY

$26.66
+0.04% today

Updated 2026-05-04

Market cap
$1.42B
P/E ratio
P/S ratio
19.29x
EPS (TTM)
$-3.94
Dividend yield
52W range
$10 – $27
Volume
2.9M

Kalvista Pharmaceuticals Inc (KALV) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item2013201420142015201520162016201720182019202020212022202320242025
Total assets$8.53M$10.11M$6.64M$6.64M$56.79M$49.67M$24.75M$34.34M$61.39M$118.13M$92.53M$272.01M$203.88M$183.20M$235.40M$250.77M
Cash & equivalents$8.24M$9.78M$3.90M$3.90M$53.72M$48.45M$21.76M$30.95M$51.05M$32.01M$15.79M$50.59M$30.73M$56.24M$31.79M$98.64M
Current assets$8.32M$9.91M$4.59M$4.59M$54.95M$49.47M$24.67M$34.25M$59.38M$115.55M$88.70M$264.26M$193.65M$172.33M$225.69M$241.69M
Total liabilities$36.81M$43.81M$11.27M$50.83M$7.48M$6.60M$3.25M$3.02M$34.14M$21.39M$8.78M$14.82M$18.79M$22.18M$28.82M$155.38M
Current liabilities$3.07M$3.95M$7.09M$7.09M$4.27M$3.85M$3.25M$3.02M$23.22M$18.05M$7.72M$9.77M$11.58M$15.03M$22.81M$45.17M
Long-term debt$2.13M$3.15M$2.70M$2.70M$0.00$58000.00
Shareholder equity$-28.29M$-33.71M$-4.63M$-44.18M$49.31M$43.07M$21.50M$31.33M$27.25M$96.74M$83.75M$257.19M$185.09M$161.03M$206.58M$95.39M
Retained earnings$-28.74M$-34.42M$-47.77M$-47.77M$-72.62M$-79.23M$-37.25M$-55.85M$-71.66M$-92.48M$-121.59M$-167.84M$-250.18M$-343.08M$-469.73M$-653.17M
Accounts receivable$235.00$2.24M$2.24M$2.55M$6.83M$11.31M$16.53M$11.72M$16.81M$18.64M$10.87M$15.14M
Inventory$-235.00$0.00$0.00$0.00$2.71M
Goodwill$0.00$0.00$0.00